Article
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.
World journal of gastroenterology - 28 Jul 2009
Lakatos Peter Laszlo, Czegledi Zsofia, Szamosi Tamas, Banai Janos, David Gyula, Zsigmond Ferenc, Pandur Tunde, Erdelyi Zsuzsanna, Gemela Orsolya, Papp Janos, Lakatos Laszlo
Abstract excerpt
AIM: To assess the combined effect of disease phenotype, smoking and medical therapy [steroid, azathioprine (AZA), AZA/biological therapy] on the probability of disease behavior change in a Caucasian cohort of patients with Crohn's disease (CD). METHODS: Three hundred and forty well-characterized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.